Table 5.
Multivariable Logistic Regression Examining Predictors of Failure to Achieve Low-Density Lipoprotein Cholesterol Target for Men Receiving Statin Therapy (HIV+/HIV− Men)
| Univariate | Multivariate (N=333) | |
|---|---|---|
| HIV (infected vs. uninfected) | 0.94 (0.55, 1.62) | 0.78 (0.38, 1.62) |
| Age | 0.97 (0.94, 1.01) | 0.97 (0.93, 1.02) |
| Race | ||
| Black (reference) | 1 | 1 |
| Hispanic/other race | 1.09 (0.37, 3.16) | 1.05 (0.28, 4.03) |
| White | 0.45 (0.22, 0.93) | 0.72 (0.29, 1.74) |
| Body mass index category | ||
| <25 mg/kg2 (reference) | 1 | 1 |
| 25–30 | 0.91 (0.46, 1.79) | 0.87 (0.38, 1.95) |
| >30 | 1.53 (0.78, 2.96) | 0.93 (0.39, 2.25) |
| Diabetes | 5.70 (2.88, 11.25) | 5.31 (2.47, 11.42) |
| Current smoking | 2.65 (1.47, 4.78) | 2.72 (1.30, 5.67) |
| Hypertension | 1.79 (1.01, 3.15) | 1.85 (0.91, 3.76) |
| No medical insurance | 2.90 (0.86, 9.72) | 1.12 (0.17, 7.41) |
| No insurance coverage for medications | 3.12 (1.35, 7.23) | 2.63 (0.86, 8.04) |
| Statin potency (high vs. low) | 0.68 (0.36, 1.29) | 0.60 (0.28, 1.31) |
| Family history of premature CHD | 1.32 (0.72, 2.44) | ** |
| Chronic HCV | 0.78 (0.10, 6.32) | ** |
| AST or ALT >80 U/liter | 3.23 (0.79, 13.27) | * |
| Current fibrate use | 1.32 (0.61, 2.87) | * |
*
NS (p>0.10) in univariate.
**
Excluded due to poor model fit.